What is LOPJLB’s current signal on CYTK?

LOPJLB’s latest quantitative signal on Cytokinetics, Incorporated (CYTK) is SELL in a BEAR regime. Signals are updated daily.

What market regime is CYTK in?

Cytokinetics, Incorporated (CYTK) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Cytokinetics, Incorporated (CYTK) do?

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, or…

Where is Cytokinetics, Incorporated based / listed?

Cytokinetics, Incorporated is based in US, listed on NASDAQ.

Cytokinetics, Incorporated (CYTK)

Healthcare · Biotechnology · NASDAQ · US

$77.09+0.33%Close

SELLBEAR · day 20

[SCORES & PROFILE]

FUND: 6
VALUE: 10
GROWTH: 11
GARP: 5
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC98.4%

REV YoY-

ROE164.0%

EPS YoY-

ROA-46.5%

GROSS

-993

NET

-1260

[VALUATION]

P/E TTM-10.69

P/E FWD-

SECTOR PE22.66

INDUSTRY PE17.07

P/B-58.69

P/FCF-

EV/EBITDA-12.96

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO6.66

ND/EBITDA-

BETA0.38

Cytokinetics, Incorporated (CYTK)

Key stats

Sector peers

Industry peers

Prediction markets

FUNDAMENTALS

Company news